Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
Aying Wang, Tangfeng Lv, Yong Song
Topics & Concepts
Chimeric antigen receptorMUC1Cancer researchAntigenAntibodyLung cancerIn vivoT cellImmunologyBiologyMedicineImmune systemOncologyBiotechnologyCAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses